Health Articles

RSS

What Is Culinary Medicine? Bridging Nutrition, Cooking, and Health

Culinary medicine combines nutrition science with practical cooking education to help patients apply dietary advice and train healthcare professionals in nutrition counseling. Studies report improvements in cooking confidence and dietary behaviors, but evidence for sustained clinical benefits remains limited.

20 Oct 2026

How Non-Alcoholic Drinks Affect the Brain: Reward, Rituals, and Expectations

Flavor cues, drinking rituals, and learned expectations can shape brain activity, perceived intoxication, and alcohol craving without substantial alcohol exposure. Research on alcohol-free alternatives remains limited, particularly regarding long-term alcohol reduction and outcomes in people with alcohol use disorder.

20 Oct 2026

Metaflammation Explained: How Obesity, Diabetes, and Aging Are Connected

Obesity-associated metaflammation involves persistent, low-grade inflammation that disrupts insulin signaling and contributes to metabolic disease, with mechanisms that overlap with age-related inflammation. Weight loss and established metabolic treatments can reduce some inflammatory effects, while therapies targeting specific immune and microbial pathways remain under investigation.

29 Oct 2026

Glycation and Aging: How Sugar Damage Affects Skin, Cells, and Health

Glycation produces advanced glycation end products (AGEs) that can alter proteins, impair skin elasticity, and promote inflammation and oxidative stress. Human studies link AGE accumulation to diabetic complications, but whether reducing dietary AGEs slows aging remains uncertain.

29 Oct 2026

Metabolomics and Nutrition: What Happens to Food Inside the Body

By replacing self-reported food logs with objective biomarkers, metabolic profiling enables personalized precision nutrition and better disease risk prediction.

29 Oct 2026

Epigenetic Changes in Aging: How Gene Expression Shifts over Time

Aging alters DNA methylation, histone modifications, chromatin organization, and regulatory RNA activity, affecting gene expression and cellular function. Epigenetic clocks and reprogramming experiments help researchers investigate these changes, but their use in personalized aging care requires further validation.

28 Oct 2026

Human Evolution and Disease: How Ancient DNA Shapes Modern Health Risks

Ancient DNA and evolutionary medicine help explain how inherited genetic variants interact with changing environments to influence modern disease risk. Neanderthal ancestry, metabolic variation, and evolutionary trade-offs provide insights into immunity, obesity, type 2 diabetes, and aging.

28 Oct 2026

How Functional Foods Deliver Bioactive Compounds and Support Gut Health

Functional foods use delivery systems such as encapsulation, lipid carriers, and hydrogels to protect bioactive ingredients and control their release during digestion. These technologies may improve nutrient availability, but human studies are needed to establish their health benefits and long-term safety.

26 Oct 2026

Stem Cell Aging: Why Tissue Repair Slows With Age

Aging can impair stem cell self-renewal and differentiation through molecular damage, inflammation, and changes in the surrounding tissue environment, contributing to slower repair. Experimental approaches have restored aspects of stem cell function in laboratory and animal studies, but evidence has yet to establish safe and effective methods for reversing stem cell aging in humans.

26 Oct 2026

GLP-1 Receptor Agonists Reduce Kidney Disease Risk: What Clinical Trials Show

GLP-1 receptor agonists reduce albuminuria and slow kidney function decline, with the strongest clinical evidence supporting semaglutide in people with type 2 diabetes and chronic kidney disease. Benefits in selected populations without diabetes, combination treatments, and tirzepatide warrant further study, particularly for preventing kidney failure and treating advanced disease.

28 Oct 2026

Melatonin and Cancer: What Research Shows About Benefits and Risks

Melatonin influences cancer cell metabolism, immune responses, and programmed cell death in laboratory and animal studies. Clinical findings remain mixed, and research has not established that melatonin supplements prevent cancer or improve cancer control.

27 Oct 2026

Maqui Berry: Health Benefits, Nutrition, and Uses

Maqui berries contain anthocyanins and other polyphenols studied for their antioxidant activity and effects on inflammation, glucose regulation, and eye health. Human trials suggest possible benefits for postprandial blood glucose and dry-eye symptoms, but evidence for healthy aging and long-term safety remains limited.

23 Oct 2026

Jaboticaba Fruit: What Are Its Potential Health Benefits?

Jaboticaba contains polyphenols and dietary fiber that researchers are studying for their effects on oxidative stress, gut microbiota, and metabolic health. Small human trials suggest improvements in selected glucose and inflammatory markers, but most evidence remains preclinical, and effective doses and long-term safety require further study.

22 Oct 2026

What Is Inflammaging? Causes, Health Effects, and Ways to Reduce Inflammation

Inflammaging is a state of persistent, low-grade inflammation associated with aging, influenced by immune dysfunction, cellular senescence, oxidative stress, and changes in the gut microbiome. This article examines how inflammaging contributes to age-related diseases, including cardiovascular disease, diabetes, and neurodegeneration, while exploring the potential of lifestyle interventions and emerging therapies to regulate chronic inflammation and support healthy aging.

22 Oct 2026

GLP-1 Drugs and Eating Disorders: What Research Shows About Benefits, Misuse, and Mental Health

The growing demand for GLP-1 drugs has raised concerns about potential misuse and the lack of evidence guiding their use outside approved indications.

27 Oct 2026

How GLP-1 Drugs Affect the Brain Beyond Weight Loss

Growing evidence suggests that GLP-1 drugs may influence mood, reward processing, cognition, reproductive health, and neurodegenerative diseases.

22 Oct 2026

How GLP-1 Drugs May Affect Crohn’s Disease and Ulcerative Colitis

GLP-1 receptor agonists support weight loss and metabolic control in people with inflammatory bowel disease, while preclinical studies suggest possible anti-inflammatory effects. Observational studies associate their use with fewer adverse IBD outcomes in some populations, but randomized trials are needed to establish clinical benefits.

26 Oct 2026

How GLP-1 Drugs May Help Psoriasis and Hidradenitis Suppurativa

GLP-1 receptor agonists are increasingly being studied for potential dermatologic applications due to their anti-inflammatory effects.

22 Oct 2026

How GLP-1 Drugs Affect Cancer Risk: Evidence, Mechanisms, and Safety

GLP-1 receptor agonists are associated with lower rates of some cancers in observational studies, but randomized trials have not established cancer prevention or improved survival after diagnosis. Possible effects beyond weight loss remain under investigation, while thyroid and colorectal cancer signals require further study.

21 Oct 2026

Can GLP-1 Drugs Help Treat Osteoarthritis and Relieve Joint Pain?

GLP-1 receptor agonists may improve knee osteoarthritis symptoms through weight loss, while laboratory studies suggest additional anti-inflammatory and cartilage-protective effects. Clinical findings vary between drugs, and randomized trials have yet to establish whether these therapies slow structural joint damage.

21 Oct 2026